Order:
Disambiguations
Jenny Dyck Brian [6]Jennifer Dyck Brian [2]Jessica Brian [1]
  1.  43
    My Bioethics Will Be Intersectional or It Will Be [Bleep].Patrick R. Grzanka, Jenny Dyck Brian & Janet K. Shim - 2016 - American Journal of Bioethics 16 (4):27-29.
  2.  16
    Clinical Encounters: The Social Justice Question in Intersectional Medicine.Patrick Ryan Grzanka & Jenny Dyck Brian - 2019 - American Journal of Bioethics 19 (2):22-24.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  3.  15
    Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust.Matthew Herder & Jennifer Dyck Brian - 2008 - Journal of Business Ethics 77 (1):73-84.
    This paper examines one nascent entrepreneurial endeavour intended by Canada's Stem Cell Network to catalyze the commercialization of stem cell research: the creation of a company called "Aggregate Therapeutics". We argue that this initiative, in its current configuration, is likely to result in a breach of public trust owing to three inter-related concerns: conflicts of interest; corporate influence on the university research agenda; and the failure to provide some form of direct return for the public's substantial tax dollar investment. These (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  4.  14
    What's the Use? Disparate Purposes of U.S. Federal Bioethics Commissions.Jenny Dyck Brian & Robert Cook-Deegan - 2017 - Hastings Center Report 47 (S1):14-16.
    In the forty‐year history of U.S. bioethics commissions, these government‐sanctioned forums have often demonstrated their power to address pressing problems and to enable policy change. For example, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, established in 1974, left a legacy of reports that were translated into regulations and had an enormous practical impact. And the 1982 report Splicing Life, by the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  54
    Bioethics and politics: Rules of engagement.Jenny Dyck Brian & Adam Briggle - 2009 - American Journal of Bioethics 9 (2):59 – 61.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  6.  12
    Exploring the Neural Structures Underlying the Procedural Memory Network as Predictors of Language Ability in Children and Adolescents With Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder.Teenu Sanjeevan, Christopher Hammill, Jessica Brian, Jennifer Crosbie, Russell Schachar, Elizabeth Kelley, Xudong Liu, Robert Nicolson, Alana Iaboni, Susan Day Fragiadakis, Leanne Ristic, Jason P. Lerch & Evdokia Anagnostou - 2020 - Frontiers in Human Neuroscience 14.
    Introduction: There is significant overlap in the type of structural language impairments exhibited by children with autism spectrum disorder and children with attention deficit hyperactivity disorder. This similarity suggests that the cognitive impairment contributing to the structural language deficits in ASD and ADHD may be shared. Previous studies have speculated that procedural memory deficits may be the shared cognitive impairment. The procedural deficit hypothesis argues that language deficits can be explained by differences in the neural structures underlying the procedural memory (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  7.  37
    Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust. [REVIEW]Matthew Herder & Jennifer Dyck Brian - 2008 - Journal of Business Ethics 77 (1):73 - 84.
    This paper examines one nascent entrepreneurial endeavour intended by Canada's Stem Cell Network to catalyze the commercialization of stem cell research: the creation of a company called "Aggregate Therapeutics". We argue that this initiative, in its current configuration, is likely to result in a breach of public trust owing to three inter-related concerns: conflicts of interest; corporate influence on the university research agenda; and the failure to provide some form of direct return for the public's substantial tax dollar investment. These (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  8. Biotechnology, bioethics, and the future: a review of Ronald Bailey’s Liberation biology: Ronald Bailey, Liberation biology: The scientific and moral case for the biotech revolution. Prometheus Books, Amherst, New York, 2005, 332 pp, $30.00 , ISBN: 1-59102-227-4. [REVIEW]Jenny Dyck Brian & Jason Scott Robert - 2008 - Theoretical Medicine and Bioethics 29 (2):125-128.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations